About CareDx, Inc - CDNA
CareDx, Inc. is a company that specializes in diagnostic solutions for transplant patients, offering products and services used to monitor organ health and contribute to the care of patients before, during, and after a transplant. Their portfolio includes non-invasive testing technology to assess organ function and detect signs of transplant rejection.
What are CareDx, Inc's core values and mission statement?
CareDx, Inc's mission is focused on delivering precision medicine solutions for transplant patients and their care providers, aiming to improve long-term outcomes and quality of life. Their core values center on innovation, patient dedication, integrity, and teamwork, which drive their commitment to transforming transplant patient care through their diagnostic services and products.
Who founded CareDx, Inc and when?
CareDx, Inc. was founded by Dr. James Yee in 1998.
Who leads CareDx, Inc?
As of my last update, Peter Maag was the CEO of CareDx, Inc., a company specializing in diagnostics for transplant patients. Changes in leadership should be checked directly from the company's official communications or reliable business sources for the most current information.
Where is CareDx, Inc located, and what is its base country?
CareDx, Inc is based in South San Francisco, California, United States.
On which exchanges is CareDx, Inc traded?
CareDx, Inc. is traded on the NASDAQ stock exchange under the ticker symbol CDNA.
CareDx, Inc (CDNA) Price Live Data
The live price of CareDx, Inc (CDNA) is $9.46, with a trading volume of 175,479 in the last 24 hours. Wrapstocks updates the CDNA price in real-time. CareDx, Inc is up 0.92% in the last 24 hours. The company has a live market cap of $511,770,880.00 and a supply of 54,098,402 CDNA stocks.
CareDx, Inc (CDNA) is traded on NASDAQ Stock Exchange, and currently, the market is open; trading will be paused in 4 hours and 30 minutes.